Hey revolution - unfortunately its all guess work. It was roughly 12-14 months for part A and that was 14 patients. They have may already started enrolling into part B stage 1 in Australia, but for margin of safety lets take from commencement of 2024 to enrol 26 patients. Maybe somewhere April-July 2025 given there will be an additional 5 Korean sites on top of the 7 Aus sites? Complete estimate, may be shorter, may be longer.
News: ATX Amplia Therapeutics Says Approval From Korean Regulator, page-13
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
-0.020(16.0%) |
Mkt cap ! $28.85M | |||
| Open | High | Low | Value | Volume |
| 12.5¢ | 12.5¢ | 10.5¢ | $96.03K | 838.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 77370 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 196517 | 1 |
View Market Depth
| Last trade - 16.10pm 03/09/2024 (20 minute delay) ? |
| ATX (ASX) Chart |